Product Images Fluvastatin Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Fluvastatin Sodium NDC 0093-7446 by Teva Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
fluvastatin sodium structural formula - image 1
Figure 1: Primary Endpoint – Recurrent Cardiac Events (Cardiac Death, Nonfatal MI or Revascularization Procedure) (ITT Population) - image 2
This is a statistical report of patients' survival rates. It shows the percentage of patients without events, which implies the percentage of patients who survived without any adverse conditions. It also provides related statistics such as Cox P-value, Log-Rank P-value, and Hazard Rt, along with the patients at risk based on the year of randomization. The text mentions several numeric values, representing the percentage of patients surviving after a particular year since randomization. It is not clear what type of events or patients the report refers to.*
Figure 2: Fluvastatin Capsules Intervention Prevention Study - Primary and Secondary Endpoints - image 3
This appears to be a results table of a clinical trial comparing a medication called Fivastat capsules to a placebo for the prevention of cardiac events. The table lists various endpoints such as cardiac death, non-fatal myocardial infarction, and revascularization both as a primary endpoint and as secondary endpoints. Risk reduction and Cox Risk Ratio are also mentioned. However, the output is missing some critical information and has unclear formatting, making it difficult to interpret the results.*
Figure 3: Change in Minimum Lumen Diameter (mm) - image 4
This document reports the change in minimum lumen diameter for patients taking Fluvastatin capsules versus Placebo capsules in both monotherapy and combination therapy. The results show a significant difference in minimum lumen diameter when comparing Fluvastatin capsules versus Placebo capsules. However, some parts of the text are not readable.*
Figure 4: Change in % Diameter Stenosis - image 5
80 mg, 30 tablets label - image 6
Description not available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.